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Abstract
Diabetes pathology derives from the combination of hyperglycemia and hypoinsulinemia or insulin resistance leading to
diabetic complications including diabetic neuropathy, nephropathy and retinopathy. Diabetic retinopathy is characterized
by numerous retinal defects affecting the vasculature and the neuro-retina, but the relative contributions of the loss of
retinal insulin signaling and hyperglycemia have never been directly compared. In this study we tested the hypothesis that
increased retinal insulin signaling and glycemic normalization would exert differential effects on retinal cell survival and
retinal physiology during diabetes. We have demonstrated in this study that both subconjunctival insulin administration
and systemic glycemic reduction using the sodium-glucose linked transporter inhibitor phloridzin affected the regulation of
retinal cell survival in diabetic rats. Both treatments partially restored the retinal insulin signaling without increasing plasma
insulin levels. Retinal transcriptomic and histological analysis also clearly demonstrated that local administration of insulin
and systemic glycemia normalization use different pathways to counteract the effects of diabetes on the retina. While local
insulin primarily affected inflammation-associated pathways, systemic glycemic control affected pathways involved in the
regulation of cell signaling and metabolism. These results suggest that hyperglycemia induces resistance to growth factor
action in the retina and clearly demonstrate that both restoration of glycemic control and retinal insulin signaling can act
through different pathways to both normalize diabetes-induced retinal abnormality and prevent vision loss.
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Introduction
Type 1 diabetes is characterized by multiple metabolic changes,
notably insulin deficiency and hyperglycemia. Systemic insulin
administration both restores depressed insulin signaling through
increased ligand availability, and normalizes blood glucose levels
through increased glucose uptake, storage and utilization in insulin
sensitive tissues. There has been increasing interest in dissecting
the relative contributions of hyperglycemia and hypoinsulinemia
to the pathophysiology of diabetes and diabetes complications
because current treatments for diabetes fail to normalize
metabolism or eliminate the risk of complications, and hypogly-
cemia limits the use of intensive insulin therapy [1].
A strategy to differentiate the roles of hyperglycemia and insulin
deficiency to diabetic complications is to separately restore insulin
signaling in an affected tissue without effecting glucose exposure
and to correct systemic hyperglycemia without increasing insulin
levels. Subconjunctival injection of insulin can accomplish the
former in retinal tissue, while systemic treatment with phloridzin, a
natural compound extracted from the bark of fruit trees, can
accomplich the latter. Phloridzin inhibits the sodium-linked
glucose transporters SGLT1 and SGLT2 in kidney tubular and
small intestinal epithelium [2]. Daily administration of phloridzin
in diabetic animals restores glycemic levels close to normal by
increasing renal glucose uptake and thus increased glucose
excretion, leading to decreased blood glucose levels. Administra-
tion of phloridzin to partially pancreatectomized diabetic rats
normalized plasma glucose levels without exogenous insulin
administration or raising plasma insulin concentrations [3].
Restoration of normoglycemia with phloridzin improved whole-
body insulin sensitivity [4,5] and residual pancreatic beta-cell
function in rodents [6]. Systemic phloridzin and intracerebral
insulin administration were recently used to demonstrate that
decreased local insulin signaling was the main cause of decreased
brain cholesterol biosynthesis in diabetic mice [7]. Renal function
was demonstrated to remain intact in humans with primary renal
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phloridzin has been used in numerous studies without reports of
deleterious effects on animal behavior or activity, while efficiently
normalizing systemic glycemic levels in diabetic animals [7,9,10].
SGLT inhibitors are also under evaluation in multiple Phase I and
Phase III clinical trials without reports of major side-effects
(ClinicalTrials.gov) [11].
Whereas hyperglycemia is often thought to be the primary
driver of complications progression, there is reason to suspect that
impaired insulin signaling could contribute to the retinal pathology
observed in diabetic retinopathy. We and others have shown that
diabetes depresses retinal insulin signaling with decreased kinase
activities of the insulin receptor and downstream signaling proteins
including Akt1 and Akt3 [12,13,14]. Insulin receptor and Akt
signaling regulate retinal neuronal cell survival in culture [15] and
in type 2 diabetic rats [16]. Insulin-deficient diabetes increases
retinal cell death within 4 weeks after diabetes onset in rats and
increased neuronal apoptosis has been documented in post-
mortem human eyes [17,18]. Therefore, we hypothesized that
restoration of retinal insulin signaling and glycemic normalization
would exert differential effects on retinal cell survival and retinal
physiology during diabetes. Interestingly, both insulin-independent
normalization of systemic hyperglycemia and ocular delivery of
insulin without normalization of blood glucose partially reversed
diabetes-induced retinal cell death. Further analysis demonstrated
that both normalization of hyperglycemia and increased ocular
insulin signaling reversed diabetes-induced insulin receptor/Akt
signaling defects. In keeping with these observations, transcrip-
tomic analysis demonstrated that these treatments normalized
partially overlapping sets of retinal genes that were altered by
diabetes. Thus, loss of local insulin signaling and systemic
hyperglycemia have both common and separable effects on the
retina. These findings are important for understanding the
contributions of factors in the diabetic milieu that contribute to
diabetic retinopathy and may be modifiable to improve visual
outcomes in patients.
Methods
Ethics statement
All experiments were conducted in accordance with the
Association for Research in Vision and Ophthalmology Resolution
on the Care and Use of Laboratory Animals and these studies
were specifically approved by the Penn State University (IACUC
#2008-038 and 2009-095) and University of Michigan (UCUCA
#10463) animal care and use committees.
Induction of diabetes and insulin therapies
Age-matched male Sprague-Dawley rats (Charles River, MA)
were housed under a 12 h light/dark cycle with free access to a
standard rat chow and water. Diabetes was induced by
intraperitoneal injection of streptozotocin (STZ) (65 mg/kg;
Sigma, St. Louis, MO) dissolved in sodium citrate buffer,
pH 4.5, and control rats received equivalent volumes of buffer
alone as described previously [18]. STZ-injected rats were
considered diabetic when exhibiting blood glucose levels
.13.9 mmol/l (250 mg/dl) within 5 days after diabetes induction
(One-Touch meter; Lifescan, Milpitas, CA).
Acute, short-term insulin therapy consisted of a daily subcon-
junctival injection of Novolin (20 mIU) or the control vehicle (PBS
with 0.1% BSA) for the last 4 days of the studies. This dose was
chosen on the basis of preliminary studies showing activation of
the retinal insulin receptor signaling pathway without reducing
blood glucose levels (Figure 1A). The 4 and 12 weeks diabetes
duration studies were chosen because they lead to increased
neuronal cell death, microvascular leakage, astrocyte defects,
microglial cell activation, and impaired insulin receptor signaling
[18,19,20,21,22]. Insulin-independent glycemic control was
achieved by phloridzin therapy. The rats received 2 daily sub-
cutaneous injections of phloridzin (200 mg/kg of body weight) or
vehicle alone (60% 1, 2-Propanediol) during the last 3 full days of
the experiment, as well as the morning of the 4th day, 3 h prior to
euthanasia. Blood glucose and insulin levels were monitored to
determine the efficacy of the treatment while food intake and
activity were monitored to insure that the treatments were not
appreciably affecting overall wellness. Vitreous glucose was
measured at time of harvest to monitor the effect of the therapeutic
treatments on ocular glucose levels using a glucometer as
previously described by Kirwin et al. [23].
For rapid dissection of retinas, rats were anesthetized with
injection of sodium pentobarbital, 100 mg/kg i.p., and killed by
decapitation following motor reflex loss. Retinas were immediately
frozen in liquid nitrogen and stored at 280uC until analysis (see
below).
Insulin assays
Serum and retinal insulin levels were measured by 2 different
methods: the sensitive rat RIA kit (SRI-13K Milipore/Linco), and
a Rat/Mouse insulin ELISA kit (EZRMI-13K, Millipore). For
both methods serum was obtained by promptly centrifuging the
clotted blood at 2,0006g for 15 minutes at 462uC. For the RIA,
each retina was sonicated in 120 ml of assay buffer supplied in kit
with protease inhibitor (Roche), and lysates were rocked at 4uC for
15 minutes followed by centrifugation at 10,0006 g for 10 min.
The supernatant was used for the RIA as per the manufacturer’s
protocol. Protein concentrations of tissue lysates were determined
using a DC protein assay kit (Bio-Rad, Hercules, CA) and retinal
insulin levels were normalized to total retinal protein concentra-
tion. For the ELISA, each retina was sonicated in 40 ml of lysis
buffer (10 mM HEPES, 42 mM KCl, 5 mM MgCl2, 0.1 mM
EDTA, 50 mM sodium pyrophosphate, 1 mM DTT, 1 mM
PMSF, 1 mM Na3VO4, 10 mM NaF, 10 mM benzamidine, 10%
glycerol, 1% Nonidet P-40, and one protease inhibitor tablet/
10 ml) before being centrifuged for 10 min at 10,0006ga t4 uC.
The ELISA was performed as per the manufacturer’s instructions
using the protocol option A for serum, with 10 ml of serum and
10 ml of buffer, and option B for the retinal assay, using 20 mlo f
lysate.
Cell death detection assays: ELISA and TUNEL
Apoptosis was measured by two complementary approaches
previously demonstrated to show corresponding results [24]. A
Cell Death Detection ELISA (Roche Diagnostics) was used
according to the manufacturer’s instructions with minor modifi-
cations. Briefly, after homogenizing the retinal tissue, samples were
incubated for 30 minutes and centrifuged at 100006g for 10 min
prior to 20 ml of the supernatant, as well as of the positive and
negative controls being transferred into the ELISA plate along
with the immunoreagent complex. Following incubation and
washes, the colorimetric solution was added and incubated until
the colorimetric reaction developed. After adding the stop
solution, the colorimetric signal was measured with a fluorescence
plate reader (SpectraMax Gemini EM; Molecular Devices) with
excitation at 405 and 490 nm. Cell death was also measured by
terminal transferase dUTP nick end labeling (TUNEL) with
horseradish peroxidase detection in whole-mount retinas as
described previously [18].
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Insulin receptor (IR) and insulin-like growth factor-1
(IGF-1R) IGF-1R kinase assays. Retinas were homogenized
by sonication in lysis buffer (see above) and 500 mg of tissue
lysates were immuno-precipitated using anti-IR or anti-IGF1R
antibodies (Santa Cruz), as described previously [13]. After
washing the immune complex, its specific kinase activity
was assessed using radiolabeled ATP (25 mCi/ml [
32P]-ATP,
Amersham) incorporation onto receptor specific peptides as
described previously [13]. After stopping the kinase reaction by
brief centrifugation, the supernatant was spotted onto filter papers
that then underwent several washes before being analyzed for
radioactive counts on a scintillation counter.
Akt isoform-specific kinase assays. Akt isoform-specific
kinase assays were performed as previously described [25].
Briefly, supernatants (500 mg of protein) of retinal tissue
homogenates prepared as for the IR or IGF1R kinase assay
were subjected to immunoprecipitation (1 h at 4uC) with 2 mgo f
anti-Akt-1 or Akt-3 primary antibody (Millipore). After washing
the immune complex, its specific kinase activity was assessed
using radiolabeled ATP incorporation onto a crosstide peptide
substrate (GRPRTSS-FAEG, 30 mM, Millipore) as described
above for the IR and IGF1R kinase assays. In all kinase assays
equivalent efficiency of the immunoprecipitation was verified by
immunoblot analysis of the immune complexes after sufficient
decay of the radioactivity.
RNA isolation, Real-time RT-PCR and Illumina Microarray
analysis
Total RNA from retinal tissues was isolated with Tri-Reagent/
BCP (Molecular Research Center, Cincinnati, OH) following
standard methods and quality and quantity was assessed using
the RNA 6000 Nano LabChip with an Agilent 2100 Expert
Bioanalyzer (Agilent, Palo Alto, CA). An equal quantity of RNA
from each sample was converted to cDNA using the SuperScript
First-Strand Synthesis System for RT-PCR (Invitrogen). Quanti-
tative PCR analysis was performed as described previously [26].
Briefly, quantitative PCR was performed using the 7900HT
Sequence Detection System (Applied Biosystems, Foster City, CA),
384-well optical plates, and Assay-On-Demand (Applied Biosys-
tems) gene specific primers and probes. ABI SDS 2.2.2 software
and the 2-DDCt analysis method were used to quantify relative
amounts of product using beta-actin as an endogenous control.
Beta-actin levels were determined to be unchanged in an absolute
quantification experiment (data not shown). For the Illumina
microarray, 750 ng of purified cRNA was prepared for hybrid-
ization of Illumina RatRef-12 Expression BeadChips according to
the manufacturer’s instructions. Briefly, Chips were incubated in a
hybridization oven for 20 h at 58uC before being disassembled,
washed and Streptavadin-Cy3 stained. Chips were dried and
subsequently scanned using a BeadArray Reader and images were
imported into GenomeStudio software v2010.1 (Illumina Inc, San
Diego, CA). After performing the quality controls, background
Figure 1. Subconjunctivally delivered insulin reaches the retina without having systemic effects. A dose-response study of the blood
glucose levels of non-diabetic control rats 30 minutes after subconjunctival administration of insulin was conducted and showed that doses over
0.0325 IU per 100 g of body weight significantly decreased blood glucose levels (A). Further analysis of lower doses of insulin showed that
administration of 20–40mIU of insulin had no systemic effect on serum glucose (B) or insulin (C) levels, while significantly increasing retinal insulin
levels (D).
doi:10.1371/journal.pone.0026498.g001
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ed files were imported into GeneSpring GX11.0 software (Agilent
Technologies). The array data are MIAME compliant and have
been deposited in the ArrayExpress MIAME compliant database
(accession # E-MTAB-771).
Immunohistochemistry
Immunohistochemistry was performed as previously described
[22]. Briefly, eyecups were embedded in OCT and snap-frozen in
dry ice, cooled with 2-methylbutane, directly after enucleation.
Sections (10 mm) from each experimental group were mounted on
the same slide. The slides were blocked with donkey serum before
incubations at 4uC overnight with the primary antibodies against
GFAP (Roche) and Cyanine2 conjugated secondary antibodies
were used (Jackson Immunoresearch) and after mounting in Gel/
Mount (Biomeda, Foster City, CA) the resulting immunolabeling
was examined and photographed using a confocal microscope
(Leica, Lasertechnik GmbH). Controls were prepared by omitting
the primary antibody during the incubation; no specific staining
could be detected in these controls.
Pathway Analysis
Microarray data were analyzed using the MetaCore
TM (Genego
Inc.) software suite for pathway analysis to identify the most
significant pathways affected by diabetes and reversed by the
independent treatments.
Statistical Analysis
ANOVA models with heterogeneous variances, adjusted for the
replication of the experiment, were fit to the data to assess
differences between control, diabetic and treated animals. The
means 6 SEM and statistically significant differences are reported.
Analyses were performed using non-repeated measures ANOVA
followed by the SNK test for multiple comparisons or t-test for a
single comparison.
Results
Subconjunctival administration of low dose insulin
reaches the retina without systemic effects
Systemic insulin treatment allows for relatively good control of
diabetes through mechanisms that can be attributed to normal-
ization of the glycemic levels and activation of insulin signaling
pathways in various tissues. We previously demonstrated that
intravitreal injection of insulin restores retinal IR activity [14]. To
differentiate between the two effects, we first performed a dose-
response study of subconjunctivally administered insulin followed
by analysis of glucose and insulin blood levels. Preliminary analysis
showed that blood glucose levels of non-diabetic control rats were
similarly decreased by subconjunctival insulin doses greater than
50 mIU/100 g of rat body weight (Figure 1A). We then further
analyzed the effects of doses below this threshold on blood insulin
and glucose levels as well as retinal insulin concentration.
Subconjunctival injections of 50 mIU insulin lowered blood
glucose level at 30 min after injection, whereas lower doses up to
40 mIU had no significant impact on blood glucose levels at 30
and 60 min after injection (Figure 1B). While the 80 mIU dose
raised serum insulin levels approximately 3 fold, the 20 mIU had
no effect (Figure 1C). In contrast, subconjunctival injection of the
same 20 mIU dose, significantly increased insulin content within
retinal tissue (Figure 1D). Furthermore, insulin administered by
subconjunctival injection was detected in the retinas as soon as
5 minutes after injection and was detectable for over an hour after
injection (data not shown). Therefore, the doses of subconjunctival
insulin used for subsequent studies are specific to the eye and do
not alter systemic metabolism.
Subconjunctival insulin administration specifically
increases retinal insulin signaling in diabetic rats while
phloridzin normalizes hyperglycemia in an insulin-
independent manner
The systemic effects of both local insulin and phloridzin
treatments were analyzed by monitoring glucose and insulin
serum levels. Daily subconjunctival administration of 20 mIU of
insulin for 4 consecutive days to rats with 4 weeks of STZ-induced
diabetes did not reduce the hyperglycemia (Figure 2A). Similarly,
no differences in serum insulin levels were detected between the
treated and untreated diabetic rats, demonstrating that subcon-
junctival administration of low doses of insulin had no effect on the
systemic hypoinsulinemic condition (Figure 2B). Phloridzin
administration significantly reduced mean serum glucose levels
of diabetic rats from 531 mg/dL and maintained them at normal
levels (206 mg/dL) for at least 6 h post-injection at day 2
(Figure 2A). Phloridzin had no effect on serum insulin levels
confirming that the effect of phloridzin on serum glucose levels is
independent of plasma insulin (Figure 2B). Specificity of the
treatments was also observed when rats with longer duration of
diabetes (12 weeks) were treated (Figure 2C and 2D). Ocular
effects of the treatments were also assessed by monitoring vitreous
glucose and retinal insulin levels at the end of the treatment. In
correlation with the systemic results, the mean vitreous glucose
concentrations were reduced from means of 448 to 254 mg/dL by
phloridzin treatment, but were unaffected by local insulin
administration (Figure 2E and 2F), and retinal insulin levels did
not increase in phloridzin treated rats (Figure 2G). In contrast,
subconjunctival injection of insulin in diabetic rats lead to
significantly increased retinal insulin levels (Figure 2G). Neither
local insulin administration nor systemic phloridzin treatment
significantly affected the body weights or food consumption of rats
during the 4 days of treatment (Figure 2H). Also, while retinal
insulin levels after subconjunctival injections are supra-physiologic,
they did not cause any increase in retinal cell death (Figure 3).
Together, these data demonstrate that the ocular metabolic
parameters were affected in specific manners by these pharmaco-
logical manipulations.
Increased ocular insulin signaling and systemic blood
glucose reduction protect retinal cells from diabetes-
induced cell death
We have previously demonstrated that diabetes significantly
increases retinal cell death within 4 weeks after the onset of
hyperglycemia, systemic insulin administration restores depressed
insulin receptor signaling and cell death, and intravitreal insulin
injection restores retinal insulin receptor activity [14]. In the
present study, subconjunctival administration of low-dose insulin
partially prevented this increased cell death as demonstrated by
both reduction in the number of TUNEL-positive retinal cells and
DNA fragmentation in the treated rats when compared to the
untreated diabetic animals (Figure 3A and 3B). Both subconjunc-
tival administration of low-dose insulin and systemic administra-
tion of phloridzin reversed the increased retinal cell death
observed in 4 weeks diabetic rats (Figure 3B). Interestingly,
applications of both treatments reversed diabetes-induced retinal
cell death to similar degrees (over 60%) after longer duration of
diabetes as demonstrated by the effect on both the number of
TUNEL positive cells (Figure 3C) and DNA fragmentation
(Figure 3D) in retina from 12 weeks diabetic animals. Since the
Glucose and Insulin Roles in Diabetic Retinopathy
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26498Figure 2. Distinct physiological effects of subconjunctivally delivered insulin and systemic phloridzin treatment. Two or four days of
local insulin administration (20 mIU) had no effect on serum glucose (A, C) or insulin (B, D) levels of 4 (A–B) or 12 (C–D) weeks diabetic animals, while
phloridzin administration rapidly normalized serum glucose levels at both 4 (A) and 12 (C) weeks of diabetes without affecting serum insulin levels
(B, D). Ocular insulin administration had no effect on vitreous glucose levels (E, F) while greatly increasing retinal insulin levels (G) whereas phloridzin
reduced high vitreous glucose levels (E, F) without affecting retinal insulin levels (G). Rat body weights were unaffected irrespective of the treatments
as demonstrated in 12 wks diabetic STZ-rats (H). n$8/group; *significantly different from control the same day (P,0.05);
#significantly different from
untreated diabetic the same day (P,0.05).
doi:10.1371/journal.pone.0026498.g002
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levels, they were then used in combination to test for a potential
additive effect. Surprisingly, no additive effect was observed,
suggesting that both treatments use similar or converging parallel
intracellular signaling pathways that are individually sufficient, at
least for short-term cell survival.
Subconjunctival insulin administration and phloridzin
treatment both partially restore diabetic-induced retinal
insulin signaling defects
Next, we examined the mechanisms by which subconjunctival
injection of insulin and systemic phloridzin treatment prevented
the death of retinal cells. First, we demonstrated that the increased
retinal insulin levels after subconjunctival injection of insulin in
control rats correlated with increased Akt phosphorylation when
compared to basal levels, indicating the activation of the insulin
signaling pathway and confirming the biological activity of the
exogenous insulin reaching the retina (Figure 4A). We then studied
the effects of both treatments on the insulin signaling pathway and
its disruption during diabetes. Reduction of the insulin receptor
activity induced by diabetes was partially reversed by both ocular
insulin administration and phloridzin treatment (Figure 4B). As
previously reported, neither diabetes nor any of the treatments had
any impact on retinal IGF-1 receptor activity (Figure 4C). Since
Akt isoforms are key downstream kinases of the insulin signaling
cascade and crucial elements in retinal cell survival [17], we also
analyzed their activity in response to diabetes and both treatments.
As previously demonstrated, Akt1 and Akt3 activities in the retina
were reduced by diabetes (Figure 4D and 4F). Local insulin
treatment totally restored Akt1 activity (Figure 4D), while
phloridzin treatment partially restored both Akt1 and Akt3
activities (Figure 4E and 4F). This finding suggests that both local
insulin administration and blood glucose normalization can restore
retinal insulin receptor signaling, although direct activation by the
ligand is more effective.
Increased local insulin and systemic normalization of
glycemia protect retinal neurons through different
pathways
In addition to targeted studies of the insulin receptor signaling
pathway, we also employed a discovery approach to examine the
genomic effects of insulin administration and glucose reduction. A
microarray analysis of the retinal transcriptome changes of
diabetic rats and diabetic rats that received local insulin or
Figure 3. Ocular insulin administration and serum glucose normalization can both block diabetes induced retinal cell death. Retinal
cell death was measured in diabetic rats (4 and 12 weeks duration) following local or systemic insulin administration and/or phloridzin treatment for4
days using TUNEL staining or DNA fragmentation ELISA Assay. The number of TUNEL positive cells in 4 weeks diabetic rat retinas was significantly
reduced by local insulin administration (A) while cell death rate analysis using a DNA fragmentation ELISA assay showed a significant reduction by
either local insulin administration or phloridzin treatment without additive effect when the treatments were combined (B). Similarly, the number of
TUNEL positive cells in 12 weeks diabetic rat retinas was significantly reduced by phloridzin and systemic insulin treatment (C) while cell death rate
measured using the DNA fragmentation assay was also reduced by phloridzin and local insulin administration (D). n$6/group; *significantly different
from control (P,0.05);
#significantly different from diabetic (P,0.05).
doi:10.1371/journal.pone.0026498.g003
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affected greater than 1.2 fold (statistically significant with
p,0.05) by diabetes (Table S1). Of those, close to 700 were at
least partially (30% or more when compared to untreated diabetic)
reversed by at least 1 of the 2 treatments. More than 600 of these
genes were reversed by subconjunctival insulin administration,
while only 298 were reversed by phloridzin treatment. Interest-
ingly over 200 of them were reversed by both treatment, but only a
third of them were reversed to a similar extent. Gene pathway
analysis gives critical information on the main biological aspects
that are affected by the pathological and treatment conditions, and
is critical to understanding of the pathophysiology of other diabetic
complications [27]. Interestingly, while over half of the genes
reversed by phloridzin were also reversed by local insulin
administration, pathway analysis using the MetaCore knowledge
database and software (Genego Inc.) clearly showed that local
insulin signaling primarily affects inflammatory, cytoskeleton
regulatory pathways and angiogenesis related pathways (Table 1),
while the effects of phloridzin treatment are mainly on growth
factor signaling pathways without decreasing the inflammatory
component (Table 2). This analysis strongly demonstrated that
local insulin signaling but not hyperglycemia was crucial in
controlling several aspects of the immune response to diabetes,
including the classical complement pathway, cytokine-induced
Figure 4. Ocular insulin administration and phloridzin partially restore local insulin signaling. Representative immunoblots and
quantification of Akt phosphorylation in retinas of non-diabetic rats receiving subconjunctival insulin. After 30 min, retinas were analyzed for Akt
phosphorylation. Retinal Akt serine 473 phosphorylation was significantly elevated in eyes receiving insulin (*p,0.05; A). The effect of local insulin
and phloridzin treatment on the insulin signaling pathway was measured using kinase activity assays for IR (B), IGF1R (C), Akt1 (D–E) and Akt3 (F).
Both local insulin and phloridzin treatment restored the diabetic induced IR activity after 12 weeks of diabetes (B) without any effect on the IGF1R
activity (C). Activity of the downstream kinase Akt1 was also restored by both local insulin and phloridzin treatment (D–E) while Akt3 activity was
restored by phloridzin treatment. n$8/group; *significantly different from control (P,0.05);
#significantly different from diabetic (P,0.05).
doi:10.1371/journal.pone.0026498.g004
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hyperglycemia was demonstrated to be more associated with
pathways involved in the regulation of cytoskeleton remodeling,
cell signaling and energy metabolism.
Complementary to the microarray analysis, the effects of both
treatments on a panel of previously developed mRNA biomarkers
of diabetic retinopathy [28] was analyzed and demonstrated that
the two treatments differentially affected these biomarkers. Local
insulin and phloridzin reversed 10 and 8 of the 15 biomarkers,
respectively, but only 5 of these were shared between the two
treatments (Figure 5). Also of note, our previous study found that
changes in13 of these 15 same mRNA biomarkers were
significantly reversed by systemic insulin treatment [28]. Remark-
ably, local insulin and phloridzin each reversed one of the 2
biomarkers not affected by systemic insulin (Figure 5E), QRT-
PCR analysis of this panel of genes also allowed for the validation
of the results of the microarray analysis as demonstrated by the
good accordance between the levels of expression detected by both
methods (Figure 5F).
Pathway analysis of the microarray data strongly suggested
differential effects of both treatments. The first two pathways
highlighted by the pathway analysis, G-protein signaling and IL-1
beta-dependent CFTR expression, along with the effect on ATP
metabolism suggested an impact on retinal glial cells. This
prompted us to assess the effect of both treatments on gliosis, as
indicated by Mu ¨ller cell expression of glial fibrillary acid protein
(GFAP) in the retinas of diabetic animals. As shown in Figure 6,
phloridzin reversed the increased GFAP immunoreactivity in
Mu ¨ller cells from diabetic animals leading to its sole detection in
the astrocytes, while local insulin administration only partially
decreased the intensity of the gliosis. This observation again
confirms the differential mechanisms and responses involved in the
beneficial effects of the two treatments.
Discussion
Diabetic retinopathy is one of the major complications of
diabetes but the selective impact of hyperglycemia and hypoinsu-
linemia on retinal cell response have not been determined in vivo.
We previously showed that systemic insulin therapy could restore
retinal insulin signaling and prevent retinal cell death induced by
diabetes [14,18]. In the present study we employed a double
approach using phloridzin and local ocular insulin administration
to dissect the effects of decreased retinal insulin signaling and
systemic hyperglycemia and their respective roles in the patho-
Table 1. Top ten pathways affected by diabetes and reversed by ocular insulin administration.
ranking Maps min(pValue)
1 Immune response_Classical complement pathway 4.112E-12
2 Cell adhesion_Role of tetraspanins in the integrin-mediated cell adhesion 5.144E-09
3 Immune response_Lectin induced complement pathway 9.611E-08
4 Regulation of lipid metabolism_Regulation of lipid metabolism via LXR, NF-Y and SREBP 1.089E-07
5 Development_Role of IL-8 in angiogenesis 5.124E-07
6 Cytoskeleton remodeling_Regulation of actin cytoskeleton by Rho GTPases 8.567E-06
7 Immune response_IL-22 signaling pathway 7.801E-05
8 Cytoskeleton remodeling_Neurofilaments 1.972E-04
9 Immune response_IL-5 signalling 4.053E-04
10 Development_Slit-Robo signaling 4.831E-04
List of the top ten pathways obtained considering only the list of genes from the microarray analysis that were affected by diabetes and reversed by local insulin
administration using MetaCore
TM (Genego Inc.) software. Pathways are ranked based upon p-value.
doi:10.1371/journal.pone.0026498.t001
Table 2. Top ten pathways affected by diabetes and reversed by phloridzin treatment.
ranking Maps min(pValue)
1 G-protein signaling_RhoB regulation pathway 5.335E-03
2 IL-1 beta-dependent CFTR expression 5.335E-03
3 NGF activation of NF-kB 1.704E-02
4 G-protein signaling_G-Protein alpha-s signaling cascades 2.564E-02
5 Cell adhesion_Role of tetraspanins in the integrin-mediated cell adhesion 2.698E-02
6 dATP/dITP metabolism 2.798E-02
7 Signal transduction_cAMP signaling 2.836E-02
8 Regulation of lipid metabolism_Regulation of lipid metabolism via LXR, NF-Y and SREBP 2.836E-02
9 Translation _Regulation of EIF2 activity 2.976E-02
10 Transcription_NF-kB signaling pathway 2.976E-02
List of the top ten pathways obtained considering only the list of genes from the microarray analysis that were affected by diabetes and reversed by systemic phloridzin
treatment using MetaCore
TM (Genego Inc.) software. Pathways are ranked based upon p-value.
doi:10.1371/journal.pone.0026498.t002
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for the first time that hyperglycemia and decreased retinal insulin
signaling each exert common and distinct effects on retinal
pathophysiology, and that their combined disruptive effects
contribute to increased retinal cell death during diabetes. Thus,
the retina responds to both tissue insulin availability and nutrient
levels, similar to peripheral insulin-sensitive organs. These effects
involve post-translational regulation of the retinal insulin receptor
signaling pathway and gene expression changes. The restoration of
pro-survival pathways by phloridzin treatment along with the
partial effect of subconjunctival insulin administration on the same
pathways suggest retinal growth factor resistance due, at least in
part, to systemic hyperglycemia. These findings are important to
the design of therapeutic strategies to minimize hypoglycemia and
long-term complications. Targeting increased insulin action in
accessible tissues may augment the benefits of systemic insulin
therapy.
We first demonstrated that subconjunctival injection of low dose
of insulin (20 mIU) once daily for 4 days significantly increased the
retinal insulin concentration without affecting serum glucose and
insulin levels (Figure 1). We also showed that this exogenous
insulin in the retina was biologically active, as indicated by the
increase in phosphorylation on the serine 473 residue of Akt
(Figure 3), which is one of the kinases downstream of the insulin
receptor that mediates neuroprotection [29]. Likewise, we
demonstrated that twice daily subcutaneous administration of
the SGLT1 and SGLT2 glucose transporter inhibitor phloridzin,
restored normal glycemia without affecting systemic or ocular
levels of insulin (Figure 2). Rossetti et al. [6] observed increased
insulin secretion following phloridzin injections in a partially
Figure 5. Local insulin administration and phloridzin treatments differentially affect the previously characterized diabetic
retinopathy biomarker panel. PCR analysis of the expression of the 15 genes of the diabetic retinopathy biomarker panel was performed on
retinal mRNA samples from diabetic rats that received local insulin or phloridzin treatments. Local insulin (A, C) and phloridzin (B, D) respectively
normalized the expression of 10 and 8 of those 15 genes. Comparison of the effect of both treatments on the expression of the panel demonstrated
that only 5 of the normalized genes were common between the 2 treatments (E) demonstrating that they only partially overlap. Fold changes
correlation of 10 of the genes of the biomarker panel detected by microarray and qRT-PCR (F). n$4/group; *significantly different from control
(P,0.05);
#significantly different from diabetic (P,0.05).
doi:10.1371/journal.pone.0026498.g005
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showed no effect of phloridzin on serum insulin levels in a
streptozotocin-induced diabetic rat model. The difference between
these studies probably reflects a more profound loss of beta cells in
the latter model, preventing any potential stimulation of insulin
secretion by remaining beta cells. Hong et al. [4] used phloridzin
to examine the insulin-independent effects of glycemic normali-
zation on peripheral and hepatic insulin resistance. A major
difference between the brain and the retina and the peripheral
insulin-sensitive tissues is the blood-brain and blood-retinal
barriers, which control nutrient exchange between the systemic
circulation and these tissues. In this study, we used this
characteristic to independently study the effects of insulin-
independent glycemic normalization and locally-restricted insulin
signaling stimulation.
Normalization of blood glucose and increased local retinal
insulin levels both reversed the diabetes-induced retinal cell death
(Figure 3) in correlation with the reversal of retinal insulin
signaling as demonstrated by complete or partial restoration of IR
and Akt1 kinase activity (Figure 4). We have shown that retinal
insulin receptor signaling is disrupted in insulin-deficient diabetes
but it was unclear whether it results from hyperglycemia and/or
hypoinsulinemia. In the present study, we show that the
hyperglycemia was only partially responsible for the loss of activity
of the retinal insulin signaling pathway. The reversal observed
when retinal insulin levels were increased suggests that this is also
due to loss of ligand or ligand sensitivity. Insulin resistance has
been shown in the vasculature of rats with Type 2 diabetes [30]
but this is, to the best of our knowledge, the first evidence for
impaired insulin action in response to hyperglycemia in the retina.
The beneficial effects of local insulin on the viability of sensory
neurons in the retina in this study parallel the improved nerve
conduction velocity observed in diabetic rats following insulin
injection adjacent to the sciatic nerve or intrathecally [31,32].
Inflammation is increasingly understood as a central component
of diabetes and its complications. Our pathway analysis of the
effects of phloridzin and local insulin on the retinal transcriptome
changes induced by diabetes clearly demonstrated that only local
insulin specifically repressed retinal inflammation, particularly the
complement activation. Gene expression profiling comparison of
isolated Mu ¨ller cells from diabetic and non-diabetic STZ-rats
identified a large cluster of genes associated with inflammation
that were highly upregulated in diabetes [33]. Among those genes
were several components of the complement pathway and other
Figure 6. Phloridzin treatment completely reverses the diabetes-induced retinal gliosis while local insulin only reduces it.
Immunolocalization of GFAP in normal and 12 week diabetic rats after phloridzin or local insulin treatment. The retinal sections were counterstained
with Hoecht to visualize nuclei layers (blue). As previously described, GFAP was only detected in the astrocytes in control animals where it was
reduced by diabetes in correlation with an induction in the Mu ¨ller cells. While local insulin administration only reduced the intensity of the staining in
the Mu ¨ller cells, GFAP could only be detected in astrocytes of phloridzin treated rats. The sections selected are representative of the results observed
in 3 independent animals for each conditions.
doi:10.1371/journal.pone.0026498.g006
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adhesion, which has also been identified in our analysis as the
second most represented pathway specifically, reversed by local
insulin administration. Insulin’s effect on inflammation could
explain in part why local insulin was able to reduce the Mu ¨ller cell
activation observed in diabetes (Figure 6). Activation of the
complement pathway has been demonstrated by increased protein
expression of several factors such as C3, C4b, C9 and factor B in
the vitreous of diabetic patients with proliferative diabetic
retinopathy [34]. The same study also showed increased mRNA
expression of C3 and factor B in the retina from other diabetic
patients with proliferative diabetic retinopathy (PDR). These data
suggest a specific potential for ocular insulin in addition to systemic
insulin for the treatment of the inflammatory component of
diabetes complications.
The retinal lipid metabolism pathway is also specifically
restored by local insulin but not phloridzin. Several studies have
investigated the specific roles of insulin and hyperglycemia using
similar approaches to study their impact on brain metabolism.
One study showed that insulin deficiency is the major driver of
the defects in the basal hypothalamo-pituitary-adrenal function
in diabetes [35] while another study recently used intraventric-
ular insulin versus systemic phloridzin treatment to compare the
respective roles of insulin and glycemia in the control of lipid in
the brain during diabetes [7]. Suzuki et al. demonstrated that
brain insulin deficiency, rather than hyperglycemia, was directly
responsible for the reduced cholesterol biosynthesis observed
during diabetes. Cellular cholesterol and fatty acid homeostasis
are transcriptionally regulated by three members of sterol
regulatory element-binding protein (SREBP) family: SREBP-1a,
SREBP-1c, and SREBP-2. Of these, SREBP-2 preferentially
activates genes responsible for cholesterol synthesis [36]. The
authors found brain Srebf2 and Srebf1a decreased in diabetic
mice and reversed by systemic insulin. In the retina, we found
decreased Srebf2 while Srebf1 was increased, neither of which was
normalized by phloridzin, whereas local insulin totally reversed
Srebf2 but marginally affected Srebf1. In our microarray analysis,
local insulin also restored caveolin-1 expression, a protein
essential for the transport of cholesterol and sphingolipids. This
finding suggests that local insulin signaling may be important for
the regulation of retinal cholesterol synthesis and its proper
subcellular localization. Our study also suggests that local
insulin, which restored SREBP-2b u tn o tS R E B P - 1e x p r e s s i o n ,
might specifically restore cholesterol synthesis but not pertur-
bations affecting sphingolipids. This could be demonstrated by
further studying the effect of local insulin on the reduction of
fatty acid elongases observed in rats with untreated short-term
diabetes [37]. This close relationship between insulin signaling
and lipid metabolism was recentlyd e m o n s t r a t e db yt h ef a c tt h a t
disruption of plasma membrane lipid rafts with beta-cyclodex-
trin was associated with IR signaling dysfunction in retinal
neurons [38].
Pathway analysis of the specific effects of phloridzin treatment
highlighted its impact on the reversal of the deregulation of G-
protein signaling. Interestingly, among other genes, phloridzin
restored the expression of mDIA2, a protein involved in stress
f i b e rf o r m a t i o n .T h i sr e s u l tp r o m p t e du st oa s s e s st h ee f f e c to f
both treatments on the well-described reactive gliosis observed
in the retina during diabetes. We showed that while subcon-
junctival insulin administration only resulted in a reduction of
the intensity of the GFAP staining in Mu ¨ller cells, phloridzin
treatment totally restored the original expression pattern of
GFAP with the sole expression in the astrocytes. These data
suggests that phloridzin could directly reverse the reactive gliosis
induced by diabetes through the control of the expression of
mDIA2 and potentially other proteins that regulate cytoskeleton
remodeling [39]. Our analysis also showed that phloridzin
specifically restored pathways regulated by interleukin-1 beta
and nerve growth factor, the receptors for which and themselves
are expressed by retinal glial cells [40,41,42], once more
pointing out the role of Mu ¨ller cells in the effects of phloridzin
on diabetes. We showed that phloridzin but not local insulin
administration reduced ocular glucose levels. One of the effects
of elevated glucose is increased activation of the hexosamine
biosynthesis pathway (HBP), which leads to increased addition
of O-GlcNAc modifications which is known to be a mechanism
of inhibition of protein action, including the insulin signaling
pathway, by competition with activating phosphosites [43]. Our
microarray analysis revealed that phloridzin specifically re-
versed the effect of diabetes on the expression of 2 enzymes
involved in the regulation of glucosamine, heparan sulfate
(glucosamine) 3-O-sulfotransferase 2 and 5 (respectively Hs3st2
and Hs3st5). The effect of phloridzin on those enzymes could
explain the difference between activating the insulin signaling
pathway by increasing local insulin levels and restoring the same
insulin signaling pathway by normalizing systemic blood glucose
using phloridzin. This hypothesisi ss u p p o r t e db yt h ef a c tt h a t
systemic insulin similarly restores Hs3st2 expression [44] and
could explain why Mu ¨ller cells remain partially activated
(gliosis) despite local insulin-treatment while activation is totally
reversed by phloridzin treatment and systemic insulin therapy
[45], confirming that local insulin administration could
complement systemic insulin treatment.
Diabetes increases the Km of glucose transport systems across
the BRB [46] so higher concentrations of glucose in blood are
necessary for same amount to enter the retina suggesting a
mechanism in the barrier/retina partially counter-acting the
increase blood glucose and decreasing the entry of glucose in the
retina. Phloridzin is not expected to have a direct retinal effect
since SGLT2 mRNA has not been detected in the retina
confirming that the effect observed here is not related to an
ocular effect of phloridzin. However, phloridzin also has
antioxidant properties and is a better inhibitor of lipid peroxida-
tion than 17-B-estradiol [47,48]. These properties, which could be
involved in the protective role of phloridzin against diabetes in
retinal cells will be further investigated in the future.
These findings are clinically relevant because they indicate that
both systemic glucose levels and ocular insulin action influence the
viability of retinal cells via the actions of pro-survival kinases and
the expression of inflammatory mediators and lipid synthetic
pathways. Therapeutic strategies that limit nutrient levels and/or
augment ocular insulin action may enhance the prognosis for
vision in persons with diabetes.
Supporting Information
Table S1 Retinal transcriptome changes in response to
diabetes and their reversal by ocular insulin adminis-
tration or systemic phloridzin treatment.
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